Diminished Systemic and Mycobacterial Antigen Specific Anti-microbial Peptide Responses in Low Body Mass Index–Latent Tuberculosis Co-morbidity

Low body mass index (BMI) is a risk factor for progression from latent Mycobacterium tuberculosis infection to active tuberculosis (TB) disease. Anti-microbial peptides (AMPs) are multifunctional molecules that play a crucial role in the mammalian host innate defense mechanism. AMPs have been shown...

Full description

Bibliographic Details
Main Authors: Anuradha Rajamanickam, Saravanan Munisankar, Chandra Kumar Dolla, Subash Babu
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-04-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fcimb.2020.00165/full
_version_ 1819159000709595136
author Anuradha Rajamanickam
Saravanan Munisankar
Chandra Kumar Dolla
Subash Babu
Subash Babu
author_facet Anuradha Rajamanickam
Saravanan Munisankar
Chandra Kumar Dolla
Subash Babu
Subash Babu
author_sort Anuradha Rajamanickam
collection DOAJ
description Low body mass index (BMI) is a risk factor for progression from latent Mycobacterium tuberculosis infection to active tuberculosis (TB) disease. Anti-microbial peptides (AMPs) are multifunctional molecules that play a crucial role in the mammalian host innate defense mechanism. AMPs have been shown to have an important role in host immunity to TB infection. The association of antimicrobial peptides with low BMI–latent tuberculosis (LTBI) co-morbidity has not been explored. To study the association of AMPs with LTBI-BMI, we examined the systemic, baseline, and mycobacterial antigen stimulated levels of human neutrophil peptides 1–3, (HNP1-3), granulysin, human beta defensin–2 (HBD-2), and cathelicidin (LL-37) in individuals with LTBI and low BMI (LBMI) and compared them with individuals with LTBI and normal BMI (NBMI). LBMI was characterized by diminished systemic levels of HNP1-3, granulysin, HBD-2 and cathelicidin in comparison with NBMI. Similarly, LBMI was also characterized by diminished unstimulated levels of HNP1-3 and granulysin and diminished mycobacterial antigen stimulated levels of HNP1-3, granulysin, and HBD-2. In addition, certain AMPs exhibited a positive correlation with BMI. Our data, therefore, demonstrates that coexistent LBMI in LTBI is characterized by the diminished levels of HNP1-3, granulysin, HBD-2, and cathelicidin, thereby potentially increasing the risk of progression to active TB.
first_indexed 2024-12-22T16:33:36Z
format Article
id doaj.art-ac6376fc0527412f8108eb756e619870
institution Directory Open Access Journal
issn 2235-2988
language English
last_indexed 2024-12-22T16:33:36Z
publishDate 2020-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular and Infection Microbiology
spelling doaj.art-ac6376fc0527412f8108eb756e6198702022-12-21T18:20:01ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882020-04-011010.3389/fcimb.2020.00165531284Diminished Systemic and Mycobacterial Antigen Specific Anti-microbial Peptide Responses in Low Body Mass Index–Latent Tuberculosis Co-morbidityAnuradha Rajamanickam0Saravanan Munisankar1Chandra Kumar Dolla2Subash Babu3Subash Babu4National Institute of Health-NIRT-International Center for Excellence in Research, Chennai, IndiaNational Institute of Health-NIRT-International Center for Excellence in Research, Chennai, IndiaDepartment of Epidemiology, National Institute for Research in Tuberculosis, Chennai, IndiaNational Institute of Health-NIRT-International Center for Excellence in Research, Chennai, IndiaLaboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United StatesLow body mass index (BMI) is a risk factor for progression from latent Mycobacterium tuberculosis infection to active tuberculosis (TB) disease. Anti-microbial peptides (AMPs) are multifunctional molecules that play a crucial role in the mammalian host innate defense mechanism. AMPs have been shown to have an important role in host immunity to TB infection. The association of antimicrobial peptides with low BMI–latent tuberculosis (LTBI) co-morbidity has not been explored. To study the association of AMPs with LTBI-BMI, we examined the systemic, baseline, and mycobacterial antigen stimulated levels of human neutrophil peptides 1–3, (HNP1-3), granulysin, human beta defensin–2 (HBD-2), and cathelicidin (LL-37) in individuals with LTBI and low BMI (LBMI) and compared them with individuals with LTBI and normal BMI (NBMI). LBMI was characterized by diminished systemic levels of HNP1-3, granulysin, HBD-2 and cathelicidin in comparison with NBMI. Similarly, LBMI was also characterized by diminished unstimulated levels of HNP1-3 and granulysin and diminished mycobacterial antigen stimulated levels of HNP1-3, granulysin, and HBD-2. In addition, certain AMPs exhibited a positive correlation with BMI. Our data, therefore, demonstrates that coexistent LBMI in LTBI is characterized by the diminished levels of HNP1-3, granulysin, HBD-2, and cathelicidin, thereby potentially increasing the risk of progression to active TB.https://www.frontiersin.org/article/10.3389/fcimb.2020.00165/fulllow BMIlatent tuberculosisanti-microbial peptidesHNP1-3granulysinHBD-2
spellingShingle Anuradha Rajamanickam
Saravanan Munisankar
Chandra Kumar Dolla
Subash Babu
Subash Babu
Diminished Systemic and Mycobacterial Antigen Specific Anti-microbial Peptide Responses in Low Body Mass Index–Latent Tuberculosis Co-morbidity
Frontiers in Cellular and Infection Microbiology
low BMI
latent tuberculosis
anti-microbial peptides
HNP1-3
granulysin
HBD-2
title Diminished Systemic and Mycobacterial Antigen Specific Anti-microbial Peptide Responses in Low Body Mass Index–Latent Tuberculosis Co-morbidity
title_full Diminished Systemic and Mycobacterial Antigen Specific Anti-microbial Peptide Responses in Low Body Mass Index–Latent Tuberculosis Co-morbidity
title_fullStr Diminished Systemic and Mycobacterial Antigen Specific Anti-microbial Peptide Responses in Low Body Mass Index–Latent Tuberculosis Co-morbidity
title_full_unstemmed Diminished Systemic and Mycobacterial Antigen Specific Anti-microbial Peptide Responses in Low Body Mass Index–Latent Tuberculosis Co-morbidity
title_short Diminished Systemic and Mycobacterial Antigen Specific Anti-microbial Peptide Responses in Low Body Mass Index–Latent Tuberculosis Co-morbidity
title_sort diminished systemic and mycobacterial antigen specific anti microbial peptide responses in low body mass index latent tuberculosis co morbidity
topic low BMI
latent tuberculosis
anti-microbial peptides
HNP1-3
granulysin
HBD-2
url https://www.frontiersin.org/article/10.3389/fcimb.2020.00165/full
work_keys_str_mv AT anuradharajamanickam diminishedsystemicandmycobacterialantigenspecificantimicrobialpeptideresponsesinlowbodymassindexlatenttuberculosiscomorbidity
AT saravananmunisankar diminishedsystemicandmycobacterialantigenspecificantimicrobialpeptideresponsesinlowbodymassindexlatenttuberculosiscomorbidity
AT chandrakumardolla diminishedsystemicandmycobacterialantigenspecificantimicrobialpeptideresponsesinlowbodymassindexlatenttuberculosiscomorbidity
AT subashbabu diminishedsystemicandmycobacterialantigenspecificantimicrobialpeptideresponsesinlowbodymassindexlatenttuberculosiscomorbidity
AT subashbabu diminishedsystemicandmycobacterialantigenspecificantimicrobialpeptideresponsesinlowbodymassindexlatenttuberculosiscomorbidity